Home > Qtrly Results > PIRAMAL PHARMA

PIRAMAL PHARMA
Quarterly Results Analysis [Mar2024]

PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Quarterly Results

Consolidated Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Revenues ₹2,552 Cr ₹1,959 Cr ₹1,911 Cr ₹1,749 Cr ₹2,164 Cr ₹1,716 Cr ₹1,720 Cr ₹1,482 Cr
Expenses ₹2,022 Cr ₹1,690 Cr ₹1,646 Cr ₹1,617 Cr ₹1,812 Cr ₹1,629 Cr ₹1,547 Cr ₹1,465 Cr
Operating Income ₹530 Cr ₹268 Cr ₹266 Cr ₹132 Cr ₹351 Cr ₹87 Cr ₹173 Cr ₹17 Cr
Other Income ₹26 Cr ₹62 Cr ₹49 Cr ₹38 Cr ₹25 Cr ₹83 Cr ₹46 Cr ₹72 Cr
Interest ₹114 Cr ₹106 Cr ₹110 Cr ₹119 Cr ₹104 Cr ₹95 Cr ₹83 Cr ₹62 Cr
Depreciation ₹196 Cr ₹186 Cr ₹185 Cr ₹174 Cr ₹184 Cr ₹164 Cr ₹166 Cr ₹162 Cr
Profit Before Tax ₹215 Cr ₹5 Cr ₹20 Cr ₹-122 Cr ₹87 Cr ₹-89 Cr ₹-37 Cr ₹-135 Cr
Profit After Tax ₹89 Cr ₹-4 Cr ₹-14 Cr ₹-113 Cr ₹42 Cr ₹-106 Cr ₹-48 Cr ₹-129 Cr
EPS ₹0.77 ₹0.08 ₹0.04 ₹-0.81 ₹0.41 ₹-0.74 ₹-0.31 ₹-0.90
Industry Peers & Returns1W1M1Y
PIRAMAL PHARMA 2.9% 9.1% 105.8%
SUN PHARMACEUTICAL INDUSTRIES 0.7% -4.8% 57.3%
CIPLA 1.9% -2.4% 42.6%
DR REDDYS LABORATORIES -5.4% -4.1% 20%
ZYDUS LIFESCIENCES 1.3% 0.5% 87.4%
DIVIS LABORATORIES 0.1% 3% 12.1%
MANKIND PHARMA -1.7% -7.8% 57.2%
TORRENT PHARMACEUTICALS -0.5% 1% 57.7%
LUPIN 4.8% 5.2% 115.9%

PIRAMAL PHARMA Quarterly Revenues

Revenues
Q-o-Q

30.32 %

Y-o-Y

17.97 %

Quarters Revenues % Change
Mar2024 ₹2,552 Cr
30.32
Dec2023 ₹1,959 Cr
2.47
Sep2023 ₹1,911 Cr
9.29
Jun2023 ₹1,749 Cr
-19.17
Mar2023 ₹2,164 Cr
26.08
Dec2022 ₹1,716 Cr
-0.23
Sep2022 ₹1,720 Cr
16.06
Jun2022 ₹1,482 Cr -

PIRAMAL PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

97.46 %

Y-o-Y

50.86 %

Quarters Operating Profit % Change
Mar2024 ₹530 Cr
97.46
Dec2023 ₹268 Cr
1.03
Sep2023 ₹266 Cr
100.76
Jun2023 ₹132 Cr
-62.33
Mar2023 ₹351 Cr
302.23
Dec2022 ₹87 Cr
-49.39
Sep2022 ₹173 Cr
910.30
Jun2022 ₹17 Cr -
Operating Margins
Q-o-Q

51.53 %

Y-o-Y

27.83 %

Quarters Operating Margin% % Change
Mar2024 20.76%
51.53
Dec2023 13.7%
-1.44
Sep2023 13.9%
83.62
Jun2023 7.57%
-53.39
Mar2023 16.24%
219.06
Dec2022 5.09%
-49.25
Sep2022 10.03%
772.17
Jun2022 1.15% -

PIRAMAL PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Positive

Y-o-Y

110.80 %

Quarters Profit After Tax % Change
Mar2024 ₹89 Cr
Positive
Dec2023 ₹-4 Cr
Negative
Sep2023 ₹-14 Cr
Negative
Jun2023 ₹-113 Cr
Negative
Mar2023 ₹42 Cr
Positive
Dec2022 ₹-106 Cr
Negative
Sep2022 ₹-48 Cr
Negative
Jun2022 ₹-129 Cr -
PAT Margins
Q-o-Q

Positive

Y-o-Y

78.57 %

Quarters PAT Margin(%) % Change
Mar2024 3.5 %
Positive
Dec2023 -0.2 %
Negative
Sep2023 -0.74 %
Negative
Jun2023 -6.46 %
Negative
Mar2023 1.96 %
Positive
Dec2022 -6.16 %
Negative
Sep2022 -2.82 %
Negative
Jun2022 -8.7 % -

PIRAMAL PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

862.50 %

Y-o-Y

87.80 %

Quarters EPS % Change
Mar2024 ₹0.77
862.50
Dec2023 ₹0.08
100.00
Sep2023 ₹0.04
Positive
Jun2023 ₹-0.81
Negative
Mar2023 ₹0.41
Positive
Dec2022 ₹-0.74
Negative
Sep2022 ₹-0.31
Negative
Jun2022 ₹-0.9 -

You may also like the below Video Courses